BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 18568557)

  • 1. Contrast-induced nephropathy: the wheel has turned 360 degrees.
    Thomsen HS; Morcos SK; Barrett BJ
    Acta Radiol; 2008 Jul; 49(6):646-57. PubMed ID: 18568557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and therapy strategies for contrast-induced nephropathy.
    Toprak O; Cirit M
    Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast media induced nephropathy: definition, incidence, outcome, pathophysiology, risk factors and prevention.
    Feldkamp T; Kribben A
    Minerva Med; 2008 Apr; 99(2):177-96. PubMed ID: 18431326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-induced nephropathy--prevention and risk reduction.
    Lameire NH
    Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk prediction of contrast-induced nephropathy.
    McCullough PA; Adam A; Becker CR; Davidson C; Lameire N; Stacul F; Tumlin J;
    Am J Cardiol; 2006 Sep; 98(6A):27K-36K. PubMed ID: 16949378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Contrast-induced nephropathy].
    Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
    Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-induced nephropathy.
    Ray S; Dutta A
    Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects.
    Solomon R; Dumouchel W
    Invest Radiol; 2006 Aug; 41(8):651-60. PubMed ID: 16829749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of contrast-induced nephropathy: experience in patients undergoing cardiovascular intervention.
    McCullough P
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):335-43. PubMed ID: 16489569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists.
    Reddan D; Fishman EK
    Eur J Radiol; 2008 May; 66(2):235-45. PubMed ID: 17728089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced nephropathy: are there differences between low osmolar and iso-osmolar iodinated contrast media?
    Morcos SK
    Clin Radiol; 2009 May; 64(5):468-72. PubMed ID: 19348841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent issues in contrast-induced nephropathy.
    Kitajima K; Maeda T; Watanabe S; Sugimura K
    Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced acute kidney injury: how should at-risk patients be identified and managed?
    Laville M; Juillard L
    J Nephrol; 2010; 23(4):387-98. PubMed ID: 20349411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
    Call J; Sacrinty M; Applegate R; Little W; Santos R; Baki T; Gandhi S; Kahl F; Kutcher M
    J Invasive Cardiol; 2006 Oct; 18(10):469-74. PubMed ID: 17042103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical and renal consequences of contrast-induced nephropathy.
    Finn WF
    Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.